JP
Insider selling
Jason P Rhodes sold $65.2M of Dyne Therapeutics, Inc. (DYN) stock
Jason P Rhodes, Dir of Dyne Therapeutics, Inc. (DYN), sold 2,586,928 shares of DYN stock worth $65.2M, per an SEC Form 4 filed Aug 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 13, 2026, 4 days before it was made public.
DYN has moved -35.9% since the trade date, from $25.96 to $16.64 (Oct 9, 2026 close).
- Traded
- Aug 13, 2026
- Disclosed
- Aug 17, 2026
- Filing delay
- 4 days
- Price since
- -35.9%
- Role
- Dir
- Source
- SEC Form 4
More DYN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.